FDA Keeps Serious Warning On Pfizer Inc. Anti-Smoking Drug, Chantix

March 10, 2015 11:40 AM

15 0

The US Food and Drug Administration announced on Monday evening that it is upholding serious warning on Pfizer Inc.’s (NYSE:PFE) anti-smoking drug, Chantix, related to neuropsychiatric risks leading to seizures as well as suicidal behavior.

FDA’s recent decision to not remove the black-box warning on Pfizer’s smoking-cessation drug Chantix came on the back of a recommendation from an advisory committee who voted in October last year to keep the serious warning on the drug’s label, related to neuropsychiatric side-effects including aggr...

Read more

To category page